BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30773193)

  • 21. Short-term efficacy and safety of total skin electron beam therapy in mycosis fungoides: Systematic review and meta-analysis.
    Grandi V; Simontacchi G; Grassi T; Pileri A; Pimpinelli N
    Dermatol Ther; 2022 Nov; 35(11):e15840. PubMed ID: 36124354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma.
    Funk A; Hensley F; Krempien R; Neuhof D; Van Kampen M; Treiber M; Roeder F; Timke C; Herfarth K; Helmbold P; Debus J; Bischof M
    Eur J Dermatol; 2008; 18(3):308-12. PubMed ID: 18474461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in total skin electron beam therapy modalities for mycosis fungoides: A single-centre study.
    Canu D; Pham-Ledard A; Ouhabrache N; Beylot-Barry M
    Ann Dermatol Venereol; 2022 Sep; 149(3):180-184. PubMed ID: 35595588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular Analysis.
    Durgin JS; Jariwala NN; Wysocka M; Zhang KK; Maity A; Benoit B; Plastaras JP; Lewis DJ; Rosenthal JM; Teague JE; Berg S; Del Guzzo C; Kim EJ; Vittorio C; Haun PL; Samimi SS; Villasenor-Park J; Inverso J; Clark RA; Rook AH
    JAMA Dermatol; 2021 Jan; 157(1):90-95. PubMed ID: 33112366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose total skin electron beam therapy plus oral bexarotene maintenance therapy for cutaneous T-cell lymphoma.
    Elsayad K; Rolf D; Sunderkötter C; Weishaupt C; Müller EC; Nawar T; Stranzenbach R; Livingstone E; Stadler R; Steinbrink K; Moritz RKC; Eich HT
    J Dtsch Dermatol Ges; 2022 Mar; 20(3):279-285. PubMed ID: 34984837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrahypofractionated Low-Dose Total Skin Electron Beam in Advanced-Stage Mycosis Fungoides and Sézary Syndrome.
    Elsayad K; Weishaupt C; Moustakis C; Danzer MF; Müller EC; Rolf D; Stranzenbach R; Livingstone E; Booken N; Stadler R; Eich HT
    Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):164-170. PubMed ID: 36893819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tailoring Radiation Therapy for Patients With Limited Cutaneous T Cell Lymphoma: Preliminary Clinical Experience With Subtotal Skin Electron Therapy.
    Laughlin BS; Zaniletti I; Foster MG; Lucido J; Mangold AR; Rosenthal AC; VAN DER Walt C; Breen W; Lester S; Hoppe B; Petersen J; Armstrong MD; Bogan A; Rule WG
    Anticancer Res; 2024 Apr; 44(4):1491-1497. PubMed ID: 38537978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total skin electron beam therapy for cutaneous T-cell lymphoma: a nationwide cohort study from Denmark.
    Lindahl LM; Kamstrup MR; Petersen PM; Wirén J; Fenger-Grøn M; Gniadecki R; Iversen L; Specht L
    Acta Oncol; 2011 Nov; 50(8):1199-205. PubMed ID: 21736502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total Skin Electron Beam Therapy for Mycosis Fungoides Revisited With Adjuvant Systemic Therapy.
    Rivers CI; Singh AK
    Clin Lymphoma Myeloma Leuk; 2019 Feb; 19(2):83-88. PubMed ID: 30528417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiotherapy in the management of mycosis fungoides: indications, results, prognosis. Twenty years experience.
    Kirova YM; Piedbois Y; Haddad E; Levy E; Calitchi E; Marinello G; Le Bourgeois JP
    Radiother Oncol; 1999 May; 51(2):147-51. PubMed ID: 10435806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of low-dose total skin electron beam therapy and subsequent localized skin electron beam therapy as a therapeutic option for advanced-stage mycosis fungoides.
    Kinoshita-Ise M; Ouchi T; Izumi E; Kawaguchi O; Nagao K; Amagai M; Funakoshi T
    Clin Exp Dermatol; 2018 Jun; 43(4):437-440. PubMed ID: 29266332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total Skin Electron Beam Therapy as Part of Multimodal Treatment Strategies for Primary Cutaneous T-Cell Lymphoma.
    Elsayad K; Susek KH; Eich HT
    Oncol Res Treat; 2017; 40(5):244-252. PubMed ID: 28448985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute and sub-acute toxicity profile of ultra-hypofractionated low-dose total skin electron beam with two 4 Gy fractions for cutaneous T cell lymphoma.
    Rolf D; Elsayad K; Eich HT
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1757-1761. PubMed ID: 33219856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total Skin Electron Beam for Primary Cutaneous T-cell Lymphoma.
    Elsayad K; Kriz J; Moustakis C; Scobioala S; Reinartz G; Haverkamp U; Willich N; Weishaupt C; Stadler R; Sunderkötter C; Eich HT
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1077-86. PubMed ID: 26581145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of total skin electron beam therapy for mycosis fungoides on hair and nail loss and regrowth.
    Breneman DL; Breneman A; Ballman E; Breneman JC
    J Dermatolog Treat; 2022 Jun; 33(4):1975-1978. PubMed ID: 33755504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4/CD8 dual-positive mycosis fungoides: a previously unrecognized variant.
    Knapp CF; Mathew R; Messina JL; Lien MH
    Am J Dermatopathol; 2012 May; 34(3):e37-9. PubMed ID: 22356917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined total body X-ray irradiation and total skin electron beam radiotherapy with an improved technique for mycosis fungoides.
    Halberg FE; Fu KK; Weaver KA; Zackheim HS; Epstein EH; Wintroub BU
    Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):427-32. PubMed ID: 2666369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides.
    Navi D; Riaz N; Levin YS; Sullivan NC; Kim YH; Hoppe RT
    Arch Dermatol; 2011 May; 147(5):561-7. PubMed ID: 21576575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Expression of Fas/CD95 on CD4+ Circulating T Cells: An Exclusion Criterion in the Diagnosis of Mycosis Fungoides?
    Du-Thanh A; Portalès P; Serre-Cousiné A; Girard C; Guillot B; Dereure O
    Acta Derm Venereol; 2017 Jul; 97(7):834-837. PubMed ID: 28206666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycosis fungoides with spongiosis: a case report.
    Kashabano JJ; Rugengamazi E; Matiku SB; Mruma RM; Lugina EL
    J Med Case Rep; 2023 Nov; 17(1):458. PubMed ID: 37919795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.